Endoron Medical
Founded 2019 · 14 employees on LinkedIn · 1 known investors
Endoron Medical develops transcatheter anchoring and sealing devices for aortic procedures, including Aortodock (a nitinol docking system to stabilize transcatheter valves in low-calcium aortic regurgitation and stenosis anatomies) and Aortoseal (a multi-stapling fixation and sealing system for endovascular aneurysm repair grafts). Its products serve physicians treating patients across the aortic continuum from TAVR to EVAR.
Investors · 1
Funding
SEC filings, press & company announcements$10M disclosed across 1 of 2 rounds · 2024
- $10MSeries AJul 2024 · 4 sources
Sofinnova Partners (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Endoron Medical do?
- Endoron Medical develops transcatheter anchoring and sealing devices for aortic procedures, including Aortodock (a nitinol docking system to stabilize transcatheter valves in low-calcium aortic regurgitation and stenosis anatomies) and Aortoseal (a multi-stapling fixation and sealing system for endovascular aneurysm repair grafts). Its products serve physicians treating patients across the aortic continuum from TAVR to EVAR.
- Who are Endoron Medical's investors?
- Endoron Medical's investors include Sofinnova Partners.
- How much funding has Endoron Medical raised?
- Endoron Medical has disclosed $10M raised across 1 of its 2 known rounds.